Walleye Capital’s Precigen PGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-10,496
Closed -$68 1758
2021
Q2
$68 Buy
+10,496
New +$73.3K ﹤0.01% 1207
2020
Q2
Sell
-17,372
Closed -$59K 884
2020
Q1
$59K Buy
+17,372
New +$75K 0.01% 670
2019
Q4
Sell
-33,966
Closed -$191K 2153
2019
Q3
$194K Buy
+33,966
New +$231K 0.01% 1214
2019
Q2
Sell
-3,959
Closed -$21.3K 1959
2019
Q1
$21K Buy
+3,959
New +$27.4K ﹤0.01% 1340

Other funds holding PGEN

Walleye Capital's PGEN Position: Q3 2021 in Review

Walleye Capital sold out of Precigen (PGEN) in Q3 2021, closing a stake of 10,496 shares — an estimated $68 sold.

Walleye Capital first reported a position in PGEN in Q1 2019 and held it in 4 quarters. The position peaked at $194K in Q3 2019. 172 funds tracked by Wall St. Rank hold PGEN as of Q3 2021.

  • Walleye Capital reported no remaining Precigen position as of Q3 2021 after selling out during the quarter.
  • Walleye Capital sold 10,496 Precigen shares in Q3 2021, an estimated $68.
  • Walleye Capital first reported a position in Precigen in Q1 2019 and held it in 4 quarters.
  • Walleye Capital's Precigen position peaked at $194K in Q3 2019.
  • 172 funds tracked by Wall St. Rank held Precigen as of Q3 2021.

Based on Walleye Capital's 13F filing for Q3 2021, filed 15 Nov 2021.